SignalFDA/Bio

Natera and Angiex Partner to Assess Response to Investigational Nuclear-Delivered Antibody-Drug Conjugate™ Using Signatera™

Partnership pairs investigational ADC with Signatera to assess therapy response.

What changed

Partnership pairs investigational ADC with Signatera to assess therapy response.

Why it matters

Partnership pairs investigational ADC with Signatera to assess therapy response. — impact context not separately stored; see What changed.

Sources